Education
About Us
Working with TipRanks
Follow Us
Mycotopia Therapies (TPIA)
OTHER OTC:TPIA
Total Valuation
Mycotopia Therapies has a market cap or net worth of $53.02K. The enterprise value is ―.
Market Cap$53.02K
Enterprise Value―
Share Statistics
Mycotopia Therapies has 5,990,903 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,990,903
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mycotopia Therapies’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee0.00
Profits Per Employee-1.18M
Employee Count1
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Mycotopia Therapies is ―. Mycotopia Therapies’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Mycotopia Therapies had revenue of 0.00 and earned -1.18M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-61.22K
Operating Income-616.72K
Pretax Income-1.18M
Net Income-1.18M
EBITDA-555.51K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -279.63K and capital expenditures 0.00, giving a free cash flow of -279.63K billion.
Operating Cash Flow-279.63K
Free Cash Flow-279.63K
Free Cash Flow per Share-0.05
Dividends & Yields
Mycotopia Therapies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta5.04
52-Week Price Change-33.33%
50-Day Moving Average0.02
200-Day Moving Average0.03
Relative Strength Index (RSI)48.24
Average Volume (3m)127.13K
Important Dates
Mycotopia Therapies upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Mycotopia Therapies as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Mycotopia Therapies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
Mycotopia Therapies EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Mycotopia Therapies has $202.36K in cash and marketable securities with $1.26M in debt, giving a net cash position of $1.06M billion.
Cash & Marketable Securities$202.36K
Total Debt$1.26M
Net Cash$1.06M
Net Cash Per Share$0.18
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Mycotopia Therapies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―